Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Stockman, 2006, SARS: systematic review of treatment effects, PLoS Med, 3, e343, 10.1371/journal.pmed.0030343

Arabi, 2018, Corticosteroid therapy for critically ill patients with middle east respiratory syndrome, Am J Respir Crit Care Med, 197, 757, 10.1164/rccm.201706-1172OC

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 10.1016/S0140-6736(20)30183-5

2020

Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006

Lee, 2004, Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study, Clin Infect Dis, 39, 1247, 10.1086/424016

Xiao, 2004, Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy, Zhonghua Nei Ke Za Zhi, 43, 179

Li, 2004, Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence, Zhonghua Yi Xue Za Zhi, 84, 1348

Ni, 2019, The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis, Crit Care, 23, 99, 10.1186/s13054-019-2395-8

McGee, 2008, Use of corticosteroids in treating infectious diseases, Arch Intern Med, 168, 1034, 10.1001/archinte.168.10.1034

Corneli, 2007, A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis, N Engl J Med, 357, 331, 10.1056/NEJMoa071255

Tang, 2005, Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome, Clin Chem, 51, 2333, 10.1373/clinchem.2005.054460

Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5

2003, Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome, Chin Med J (Engl), 116, 1283

Arabi, 2017, Middle East respiratory syndrome, N Engl J Med, 376, 584, 10.1056/NEJMsr1408795

Nicholls, 2003, Lung pathology of fatal severe acute respiratory syndrome, Lancet, 361, 1773, 10.1016/S0140-6736(03)13413-7

Lee, 2011, The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness, Chest, 140, 1155, 10.1378/chest.11-0047

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 10.1016/S0140-6736(20)30211-7

Ashbaugh, 1967, Acute respiratory distress in adults, Lancet, 2, 319, 10.1016/S0140-6736(67)90168-7

Lewis, 2019, Pharmacological agents for adults with acute respiratory distress syndrome, Cochrane Database Syst Rev, 7

Venkatesh, 2018, Adjunctive glucocorticoid therapy in patients with septic shock, N Engl J Med, 378, 797, 10.1056/NEJMoa1705835

Annane, 2018, Hydrocortisone plus fludrocortisone for adults with septic shock, N Engl J Med, 378, 809, 10.1056/NEJMoa1705716

Fougères, 2010, Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status, Crit Care Med, 38, 802, 10.1097/CCM.0b013e3181c587fd